Finance

Lists
524804:BOM
Aurobindo Pharma Ltd
₹ 1,675.00
+0.82%
(+13.65) 1D
10-р сарын 15, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524804...
Open
₹ 1,645.00
High
₹ 1,684.80
Low
₹ 1,645.00
Mkt. cap
965.43Т
Avg. vol.
24.93 мян
Volume
168.00 мян
P/E ratio
26.17
52-wk high
₹ 1,739.95
52-wk low
₹ 1,080.10
EPS
₹ 64.00
Shares outstanding
585.90 сая
No. of employees
29 мян
Open
₹ 1,645.00
High
₹ 1,684.80
Low
₹ 1,645.00
Mkt. cap
965.43Т
Avg. vol.
24.93 мян
Volume
168.00 мян
P/E ratio
26.17
52-wk high
₹ 1,739.95
52-wk low
₹ 1,080.10
EPS
₹ 64.00
Shares outstanding
585.90 сая
No. of employees
29 мян
News stories
From web sources and news partners
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29.2 мян
Founded1986
HeadquartersХайдерабад, Андрапрадеш, Энэтхэг
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
82.86 тэрбум
86.46 тэрбум
88.53 тэрбум
91.50 тэрбум
Cost of goods sold
33.39 тэрбум
34.81 тэрбум
39.28 тэрбум
36.27 тэрбум
Cost of revenue
33.39 тэрбум
34.81 тэрбум
39.28 тэрбум
36.27 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.77 тэрбум
13.10 тэрбум
14.31 тэрбум
14.80 тэрбум
Operating expense
36.98 тэрбум
38.56 тэрбум
35.29 тэрбум
41.29 тэрбум
Total operating expenses
70.37 тэрбум
73.37 тэрбум
74.57 тэрбум
77.56 тэрбум
Operating income
12.49 тэрбум
13.09 тэрбум
13.96 тэрбум
13.94 тэрбум
Other non operating income
1.16 тэрбум
1.54 тэрбум
-2.51 тэрбум
2.12 тэрбум
EBT including unusual items
12.76 тэрбум
13.39 тэрбум
12.91 тэрбум
15.15 тэрбум
EBT excluding unusual items
12.76 тэрбум
14.04 тэрбум
13.59 тэрбум
15.55 тэрбум
Income tax expense
4.28 тэрбум
4.29 тэрбум
3.70 тэрбум
4.83 тэрбум
Effective tax rate
33.53%
32.03%
28.65%
31.88%
Other operating expenses
19.91 тэрбум
20.81 тэрбум
16.37 тэрбум
21.62 тэрбум
Net income
8.48 тэрбум
9.10 тэрбум
9.21 тэрбум
10.33 тэрбум
Net profit margin
10.24%
10.53%
10.41%
11.28%
Earnings per share
14.61
16.43
15.86
17.46
Interest and investment income
-
-
3.31 тэрбум
-
Interest expense
-952.40 сая
-927.70 сая
-665.50 сая
-1.02 тэрбум
Net interest expenses
-952.40 сая
-927.70 сая
2.65 тэрбум
-1.02 тэрбум
Depreciation and amortization charges
4.29 тэрбум
4.65 тэрбум
4.61 тэрбум
4.87 тэрбум
EBITDA
16.66 тэрбум
16.71 тэрбум
18.03 тэрбум
18.01 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс